The Impact of Molecular Testing on Treatment of Cancer of Unknown Primary Origin

The preponderance of data support the accuracy of molecular assay diagnoses in about 80% to 90% of patients with known advanced primary cancers and in patients with cancer of unknown primary origin.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news